Table 3.
Compound | EC50 (μM) | Max Activation | Substrate | Ref. |
---|---|---|---|---|
MDL-800 | 10 | 22-fold | H3K9ac | [100,104] |
MDL-801 | 4.1 | 25.1-fold | H3K9myr | [129] |
MDL-811 | 7.1 | >15-fold | H3K9ac, H3K56ac | [97] |
Cyanidin | 460 | 55-fold | H3K9ac | [130] |
4H-chromen | N/A | 40-fold | H3K9ac | [131] |
Quercetin | 1200 | 2-fold | H3K9ac | [132] |
UBCS039 | 38 | 3.5-fold | H3K9ac | [133] |
CL5D | 15 | 50-fold | H3K9ac | [134] |
Fucoidan | N/A | 335-fold | H3K9ac | [135] |
Oleoylethanolamide | 3.1 | 2-fold | H3K9ac | [136] |
Myristic acid | 246 | 35-fold | H3K9ac | [134] |
Nitro-fatty acid | N/A | 40-fold | H3K9myr | [137] |
12q | 0.58 | >38-fold | Ac-RYQK(Ac)-AMC | [138] |
N/A, not available.